Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Key Take away from Q Transcript :)

<< Previous

Bullboard Posts

Next >>

Comment by srtman03on Mar 28, 2024 6:43am

48 Views

Post# 35957331

RE:Key Take away from Q Transcript :)

1hot-techwoman wrote: With the resolution of outstanding litigation, our balance sheet is clean and we enjoy $18 million in cash at year-end with less than $3 million of debt and full ownership of our assets, including 3 production facilities. 2023 saw the continuation of MediPharm's turnaround and financial restructuring, positioning us for further growth in 2024 and beyond.

Better times ahead for LABS !! :) $$

They will be profitable by next Q and with no debt !!!
Market always looks forward... $$$$$

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for June 3, 2024